Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles

Rajesh Kumar, Paresh C. Ray, Dibyadyuti Datta, Geetha P. Bansal, Evelina Angov, Nirbhay Kumar

Research output: Contribution to journalArticle

Abstract

Malaria transmission-blocking vaccines (TBV) targeting sexual stages of the parasite represent an ideal intervention to reduce the burden of the disease and eventual elimination at the population level in endemic regions. Immune responses against sexual stage antigens impair the development of parasite inside the mosquitoes. Target antigens identified in Plasmodium falciparum include surface proteins Pfs230 and Pfs48/45 in male and female gametocytes and Pfs25 expressed in zygotes and ookinetes. The latter has undergone extensive evaluation in pre-clinical and phase I clinical trials and remains one of the leading target antigens for the development of TBV. Pfs25 has a complex tertiary structure characterized by four EGF-like repeat motifs formed by 11 disulfide bonds, and it has been rather difficult to obtain Pfs25 as a homogenous product in native conformation in any heterologous expression system. Recently, we have reported expression of codon-harmonized recombinant Pfs25 in Escherichia coli (CHrPfs25) and which elicited highly potent malaria transmission-blocking antibodies in mice. In the current study, we investigated CHrPfs25 along with gold nanoparticles of different shapes, size and physicochemical properties as adjuvants for induction of transmission blocking immunity. The results revealed that CHrPfs25 delivered with various gold nanoparticles elicited strong transmission blocking antibodies and suggested that gold nanoparticles based formulations can be developed as nanovaccines to enhance the immunogenicity of vaccine antigens.

Original languageEnglish (US)
Pages (from-to)5064-5071
Number of pages8
JournalVaccine
Volume33
Issue number39
DOIs
StatePublished - Sep 22 2015
Externally publishedYes

Fingerprint

Falciparum Malaria
Plasmodium falciparum
Gold
Nanoparticles
malaria
codons
Codon
antigens
teleomorphs
Antigens
Blocking Antibodies
vaccines
Escherichia coli
Malaria
Parasites
Vaccines
ookinetes
immune response
Disease Eradication
parasites

Keywords

  • Gold nanoparticles
  • Malaria
  • Transmission
  • Vaccine

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Kumar, R., Ray, P. C., Datta, D., Bansal, G. P., Angov, E., & Kumar, N. (2015). Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles. Vaccine, 33(39), 5064-5071. https://doi.org/10.1016/j.vaccine.2015.08.025

Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles. / Kumar, Rajesh; Ray, Paresh C.; Datta, Dibyadyuti; Bansal, Geetha P.; Angov, Evelina; Kumar, Nirbhay.

In: Vaccine, Vol. 33, No. 39, 22.09.2015, p. 5064-5071.

Research output: Contribution to journalArticle

Kumar, R, Ray, PC, Datta, D, Bansal, GP, Angov, E & Kumar, N 2015, 'Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles', Vaccine, vol. 33, no. 39, pp. 5064-5071. https://doi.org/10.1016/j.vaccine.2015.08.025
Kumar, Rajesh ; Ray, Paresh C. ; Datta, Dibyadyuti ; Bansal, Geetha P. ; Angov, Evelina ; Kumar, Nirbhay. / Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles. In: Vaccine. 2015 ; Vol. 33, No. 39. pp. 5064-5071.
@article{d7e79deb3df74b67b5aad24fcf935ab9,
title = "Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles",
abstract = "Malaria transmission-blocking vaccines (TBV) targeting sexual stages of the parasite represent an ideal intervention to reduce the burden of the disease and eventual elimination at the population level in endemic regions. Immune responses against sexual stage antigens impair the development of parasite inside the mosquitoes. Target antigens identified in Plasmodium falciparum include surface proteins Pfs230 and Pfs48/45 in male and female gametocytes and Pfs25 expressed in zygotes and ookinetes. The latter has undergone extensive evaluation in pre-clinical and phase I clinical trials and remains one of the leading target antigens for the development of TBV. Pfs25 has a complex tertiary structure characterized by four EGF-like repeat motifs formed by 11 disulfide bonds, and it has been rather difficult to obtain Pfs25 as a homogenous product in native conformation in any heterologous expression system. Recently, we have reported expression of codon-harmonized recombinant Pfs25 in Escherichia coli (CHrPfs25) and which elicited highly potent malaria transmission-blocking antibodies in mice. In the current study, we investigated CHrPfs25 along with gold nanoparticles of different shapes, size and physicochemical properties as adjuvants for induction of transmission blocking immunity. The results revealed that CHrPfs25 delivered with various gold nanoparticles elicited strong transmission blocking antibodies and suggested that gold nanoparticles based formulations can be developed as nanovaccines to enhance the immunogenicity of vaccine antigens.",
keywords = "Gold nanoparticles, Malaria, Transmission, Vaccine",
author = "Rajesh Kumar and Ray, {Paresh C.} and Dibyadyuti Datta and Bansal, {Geetha P.} and Evelina Angov and Nirbhay Kumar",
year = "2015",
month = "9",
day = "22",
doi = "10.1016/j.vaccine.2015.08.025",
language = "English (US)",
volume = "33",
pages = "5064--5071",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "39",

}

TY - JOUR

T1 - Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles

AU - Kumar, Rajesh

AU - Ray, Paresh C.

AU - Datta, Dibyadyuti

AU - Bansal, Geetha P.

AU - Angov, Evelina

AU - Kumar, Nirbhay

PY - 2015/9/22

Y1 - 2015/9/22

N2 - Malaria transmission-blocking vaccines (TBV) targeting sexual stages of the parasite represent an ideal intervention to reduce the burden of the disease and eventual elimination at the population level in endemic regions. Immune responses against sexual stage antigens impair the development of parasite inside the mosquitoes. Target antigens identified in Plasmodium falciparum include surface proteins Pfs230 and Pfs48/45 in male and female gametocytes and Pfs25 expressed in zygotes and ookinetes. The latter has undergone extensive evaluation in pre-clinical and phase I clinical trials and remains one of the leading target antigens for the development of TBV. Pfs25 has a complex tertiary structure characterized by four EGF-like repeat motifs formed by 11 disulfide bonds, and it has been rather difficult to obtain Pfs25 as a homogenous product in native conformation in any heterologous expression system. Recently, we have reported expression of codon-harmonized recombinant Pfs25 in Escherichia coli (CHrPfs25) and which elicited highly potent malaria transmission-blocking antibodies in mice. In the current study, we investigated CHrPfs25 along with gold nanoparticles of different shapes, size and physicochemical properties as adjuvants for induction of transmission blocking immunity. The results revealed that CHrPfs25 delivered with various gold nanoparticles elicited strong transmission blocking antibodies and suggested that gold nanoparticles based formulations can be developed as nanovaccines to enhance the immunogenicity of vaccine antigens.

AB - Malaria transmission-blocking vaccines (TBV) targeting sexual stages of the parasite represent an ideal intervention to reduce the burden of the disease and eventual elimination at the population level in endemic regions. Immune responses against sexual stage antigens impair the development of parasite inside the mosquitoes. Target antigens identified in Plasmodium falciparum include surface proteins Pfs230 and Pfs48/45 in male and female gametocytes and Pfs25 expressed in zygotes and ookinetes. The latter has undergone extensive evaluation in pre-clinical and phase I clinical trials and remains one of the leading target antigens for the development of TBV. Pfs25 has a complex tertiary structure characterized by four EGF-like repeat motifs formed by 11 disulfide bonds, and it has been rather difficult to obtain Pfs25 as a homogenous product in native conformation in any heterologous expression system. Recently, we have reported expression of codon-harmonized recombinant Pfs25 in Escherichia coli (CHrPfs25) and which elicited highly potent malaria transmission-blocking antibodies in mice. In the current study, we investigated CHrPfs25 along with gold nanoparticles of different shapes, size and physicochemical properties as adjuvants for induction of transmission blocking immunity. The results revealed that CHrPfs25 delivered with various gold nanoparticles elicited strong transmission blocking antibodies and suggested that gold nanoparticles based formulations can be developed as nanovaccines to enhance the immunogenicity of vaccine antigens.

KW - Gold nanoparticles

KW - Malaria

KW - Transmission

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84941748667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941748667&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2015.08.025

DO - 10.1016/j.vaccine.2015.08.025

M3 - Article

VL - 33

SP - 5064

EP - 5071

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 39

ER -